Personally, there are many options and I can see a position for prescribing most of them. Given, I have a massive interest in devices and there uses this doesn’t bother me. I feel the key concern is, that, many prescribers don’t have easy access to much of the literature around benefits, use of, and, practicalities of each device and where they fit into the guidelines. In many cases, it is understandable that practitioners stick with what they know best – blues and brown and let’s not forget about purple!!
It is important that we embrace changing technology and evolution of newer molecules to consider better devices which improve compliance and quicker/longer acting medicines to improve patient symptoms. This being said it is paramount to ensure at all times that the patient is engaged in their therapy and can demonstrate proper use of these inhalers. We as HCP must also be fully aware of how to use appropriately through the regular update and can demonstrate the correct technique to our patients.
In summary, there is a multicoloured swap shop of devices to choose from but in essence, there is more scope to identify a good device for each patient with equally suitable medicines to target better respiratory management. And, with lots of competition between Pharma companies -most devices are falling in price all the time…so, in many cases, cost-effectiveness is also enhanced.